A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus
Public ClinicalTrials.gov record NCT02908100. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of GDC-0853 in Patients With Moderate to Severe Active Systemic Lupus Erythematosus
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This is a study to evaluate the safety and efficacy of GDC-0853 in combination with standard of care therapy in participants with moderate to severe active systemic lupus erythematosus (SLE).
Study identification
- NCT ID
- NCT02908100
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 260 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 75 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 18, 2017
- Primary completion
- May 27, 2019
- Completion
- Jul 15, 2019
- Last update posted
- May 7, 2024
2017 – 2019
United States locations
- U.S. sites
- 19
- U.S. states
- 11
- U.S. cities
- 18
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| University of Alabama at Birmingham | Birmingham | Alabama | 35294 | — |
| Valerius Medical Group & Research Ctr of Greater Long Beach | Los Alamitos | California | 90720 | — |
| RASF-Clinical Research Center | Boca Raton | Florida | 33486 | — |
| Bay Area Arthritis and Osteoporosis | Brandon | Florida | 33511 | — |
| Omega Research Consultants | Orlando | Florida | 32810 | — |
| Clinical Research of West Florida | Tampa | Florida | 33603 | — |
| Institute of Arthritis Research | Idaho Falls | Idaho | 83404 | — |
| Via Christi Research, a division of Via Christi Hospitals Wichita, Inc. | Wichita | Kansas | 67208 | — |
| Ochsner Clinic Foundation | Baton Rouge | Louisiana | 70809 | — |
| The Arthritis & Diabetes Clinic, Inc.; Research | Monroe | Louisiana | 71203 | — |
| Albuquerque Clinical Trials | Albuquerque | New Mexico | 87102 | — |
| Saint Lawrence Health System | Canton | New York | 13617 | — |
| New York University School of Medicine | New York | New York | 10016 | — |
| Shanahan Rheumatology & Immunology, PLLC | Raleigh | North Carolina | 27617 | — |
| Ohio State University Clinical Trials Management Office | Columbus | Ohio | 43210 | — |
| Tekton Research Inc | Austin | Texas | 78745 | — |
| Accurate Clinical Research | Houston | Texas | 77058-3675 | — |
| Accurate Clinical Research | Houston | Texas | 77089 | — |
| Arthritis Clinic Of Central Texas | San Marcos | Texas | 78666 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 51 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT02908100, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 7, 2024 · Synced Sep 29, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT02908100 live on ClinicalTrials.gov.